Radiosensitization of tumour cells by cantharidin and some analogues

International Journal of Radiation Biology

Volumn 80, Issue 4, 2004, Pages 269-279

  Price, W A ^a   Stobbe, C C ^b   Park, S J ^b   Chapman, J D ^b  

^a LA SALLE UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYLACTAM; CANTHARIDIC ACID; CANTHARIDIN; HISTONE H1; HISTONE H3; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; RADIOSENSITIZING AGENT; SINGLE STRANDED DNA; THIOANHYDRIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CELL STRAIN HT29; CELL SYNCHRONIZATION; CHROMATIN; COMET ASSAY; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; MORPHOLOGY; PHOSPHORYLATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIOBIOLOGY; RADIOSENSITIVITY; RADIOSENSITIZATION; TOXICITY; TUMOR CELL; WESTERN BLOTTING;

CANTHARIDIN; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS;

MAMMALIA;

EID: 2942579784     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000410001679785     Document Type: Article

References (32)

1. ALGAN, O., STOBBE, C. C., HELT, A. M., HANKS, G. E. and CHAPMAN, J. D., 1996, Radiation inactivation of human prostate cancer cells: the role of apoptosis. Radiation Research, 146, 267-275.
2. BIADE, S., STOBBE, C. C., BOYD, J. T. and CHAPMAN, J. D., 2001, Some agents that promote chromatin compaction also radiosensitize tumor cells. International Journal of Radiation Biology, 77, 1033-1042.
3. BIADE, S., STOBBE, C. C. and CHAPMAN, J. D., 1997, The intrinsic radiosensitivity of some human tumor cells throughout their cell cycles. Radiation Research, 147, 416-421.
4. CHAPMAN, J. D., 2003, Single-hit mechanism of tumour cell killing by radiation. International Journal of Radiation Biology, 79, 71-81.
5. CHAPMAN, J. D., STOBBE, C. C., GALES, T., DAS, I. J., ZELLMER, D. L., BIADE, S. and MATSUMOTO, Y., 1999, Condensed chromatin and cell inactivation by single-hit kinetics. Radiation Research, 151, 433-441.
6. CHAPMAN, J. D., STOBBE, C. C. and MATSUMOTO, Y., 2001, Chromatin condensation and tumor cell radiosensitivity at 2 Gy. American Journal of Clinical Oncology, 24, 509-515.
7. CHENG, S., WULIJIMUREN, WANG, P., CAO, J. and LI, F., 1993, Synthesis of N-substituted norcantharidinimide and analogues. Huaxue Shiji, 15, 1-4. [in Chinese].
8. DAUBEN, W. G., KESSEL, C. R. and TAKEMURA, K. H., 1980, Synthesis of cantharidin (7 steps). Journal of Organic Chemistry, 102, 6893-6894.
9. ERDODI, F., TOTH, B., HIRANO, K., HIRANO, M., HARTSHORNE, D. J. and GERGELY, P., 1995, Endothall thioanhydride inhibits phosphatases-1 and -2A in vivo. American Journal of Physiology, 269, C1176-C1184.
10. FRANCE, M. B., ALTY, L. T. and EARL, T. M., 1999, Synthesis of a 7-oxanorbornene derivative: a two-step sequence preparation for the organic laboratory. Journal of Chemical Education, 76, 659-660.
11. GURLEY, L. R., TOBEY, R. A., WALTERS, R. A., HILDEBRAND, C. E., HOHMANN, P. G., D'ANNA, J. A., BARHAM, S. S. and DEAVAN, L. L., 1978, Histone phosphosylation and chromatin structure in synchronized mammalian cells. In J. Jeter, I. L. Cameron, G. M. Padilla and A. M. Zimmerman (eds), Cell Cycle Regulation (New York: Academic Press), pp. 37-60.
12. HIRANO, T., KOBAYASHI, R. and HIRANO, M., 1997, Condensins, chromosome condensation protein complexes containing XCAP-C, XCAP-E and a Xenopus homolog of the Drosophila Barren protein. Cell, 89, 511-521.
13. KATES, M. J. and SCHAUBLE, J. H., 1995, Facile conversion of succinnic- to maleic-type anhydrides, thioanhydrides, and imides. Journal of Organic Chemistry, 60, 6676-6677.
14. KAWAMURA, N. LI, Y.-M., ENGEL, J. L., DAUBEN, W. G. and CASIDA, J. E. 1990, Endothall thioanhydride: structural aspects of unusually high mouse toxicity and specific binding site in liver. Chemical Research in Toxicology, 3, 318-324.
15. KOSHLAND, D. and STRUNNIKOV, A., 1996, Mitotic chromosome condensation. Annual Review of Cell and Developmental Biology, 12, 305-333.
16. LAMOND, A. I. and EARNSHAW, W. C., 1998, Structure and function in the nucleus. Science, 280, 547-553.
17. LI, Y.-M. and CASIDA, J. E., 1992, Cantharidin binding protein: identification as protein phosphatase 2A. Proceedings of the National Academy of Sciences, USA, 80, 11 867-11 870.
18. 3H]endothall thioanhydride binding site. Biochemical Pharmacology, 46, 1435-1443.
19. MA, G.-E. and TAMM, C., 2000, Pig liver esterase-catalysed hydrolysis of three diesters of meso-bicyclic dicarboxylic acid and three tetraesters of tetrahydrofuran-2,3,4,5-tetracarboxylic acid. Clinical Research in Chinese Universities, 16, 369-374.
20. MATSUZAWA, M., GRAZIANO, M. J. and CASIDA, J. E., 1987, Endothal and cantharidin analogues: relation of structure to herbicidal activity and mammalian toxicity. Journal of Agricultural and Food Chemistry, 35, 823-829.
21. MCCLUSKEY, A., KEANE, M. A., MUDGEE, L. M., SIM, A. T. R., SAKOFF, J. and QUINN, R. J., 2000, Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A? European Journal of Medicinal Chemistry, 35, 957-964.
22. MCCLUSKEY, A., TAYLOR, C., QUINN, R. J., SUGANUMA, M. and FUJIKI, H., 1996, Inhibition of protein phosphatase 2A by cantharidin analogues. Bioorganic and Medicinal Chemistry Letters, 6, 1025-1028.
23. MCCLUSKEY, A., WALKOM, C., BOWTER, M. C., ACKLAND, S. P., GARDINER, E. and SAKOFF, J. A., 2001, Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A. Bioorganic and Medicinal Chemistry Letters, 11, 2941-2946.
24. NURSE, P., 1990, Universal control mechanism regulating onset of M-phase. Nature, 344, 503-508.
25. 125IUrd. International Journal of Radiation Biology, 64, 349-358.
26. REUVERS, A. P., GREENSTOCK, C. L., BORSA, J. and CHAPMAN, J. D., 1973, Studies on the mechanism of chemical radioprotection by dimethylsulphoxide. International Journal of Radiation Biology, 24, 533-536.
27. SAKOFF, J. A., ACKLAND, S. P., BALDWIN, M. L., KEANE, M. A. and MCCLUSKEY, A., 2002, Anticancer protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues. Investigational New Drugs, 20, 1-11.
28. STEEL, G. G., 1977, The Growth Kinetics of Tumors (Oxford: Oxford University Press).
29. STOBBE, C. C., PARK, S. J. and CHAPMAN, J. D., 2002, The radiation hypersensitivity of cells at mitosis. International Journal of Radiation Biology, 78, 1149-1157.
30. WALTER, W. G., 1989, Antitumor imide derivatives of 7-oxabicyclo[2.2.1] heptane-2,3-dimethyl-2,3-dicarboxylic acid. Journal of Pharmaceutical Sciences, 78, 66-67.
31. WANG, G. S., 1989, Medical uses of Mylabris in Ancient China and recent studies. Journal of Ethnopharmacology, 26, 147-162.
32. WOLFFE, A., 1998, Chromatin Structure and Function (San Diego: Academic Press).